UCB Buoyed By More Positive Bimekizumab Data

 
• By Kevin Grogan
  
Train
Still time for UCB to get on the IL-17 train • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapy Areas